Dr. Ahmed El Bershawi, MD

Dr. El Bershawi practices at Precision Surgery Center - Riverside in Riverside, California.

Dr. El Bershawi's NPI, 1619946654, was assigned on March 14, 2006. Dr. El Bershawi graduated from Cairo University School of Medicine in 1992. Dr. El Bershawi holds California license A90658.

Dr. El Bershawi's primary practice is Precision Surgery Center - Riverside, at 4234 Riverwalk Parkway Ste 140, Riverside, CA 92505. The practice phone is (951) 509-9204.

Dr. El Bershawi's primary practice is Precision Surgery Center - Riverside in Riverside, California. Dr. El Bershawi is also affiliated with Riverside Community Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. El Bershawi to 5 more hospitals, 2 group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Bershawi practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. El Bershawi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. El Bershawi is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. El Bershawi's licenses on file in 5 states: California, Kansas, Michigan, Wisconsin and New Mexico.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, hypersomnia, pulmonary heart disease and sleep apnea among the conditions Dr. El Bershawi treats.

CMS data shows 7,091 Medicare services from Dr. El Bershawi across 24 procedure codes in 2024, for 1,141 Medicare patients. Medicare paid $592,912 for them.

CMS counts 1,141 Medicare patients who saw Dr. El Bershawi in 2024. The largest group is 65 to 74, with 491 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Bershawi's median patient age at 66, with 50% women.

In 2024, Dr. El Bershawi wrote 930 Medicare Part D claims for 111 patients. 72% of them were for generic drugs. CMS names the drug for 639 of them, across 26 drugs with 11 or more claims each, at $433,217 in total drug cost. In 2023, CMS named 308 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. El Bershawi for performance year 2024, reported as part of a group. Dr. El Bershawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. El Bershawi as offering telehealth.

Dmand AI links Dr. El Bershawi to 2 clinical trials. Conditions studied include Emphysema and Lung Diseases, Interstitial. United Therapeutics sponsors the most, 2. Open Payments lists research payments to Dr. El Bershawi that name 2 trials.

CMS Open Payments shows 169 general payments to Dr. El Bershawi from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. La Jolla Pharmaceutical Company paid the most, $4,769. It also lists 3 research payments totaling $3,213 in 2020, naming 2 clinical trials.

Dmand AI lists 3 awards for Dr. El Bershawi, most recently Top Doctors:LA Area in 2013.

Dr. El Bershawi graduated from Cairo University School of Medicine in 1992. Dr. El Bershawi is a member of AASM, ACCP, ATS and CMA.

Dr. El Bershawi is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.